Clinical Trial Results: Ritlecitinib for Cicatricial Alopecia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for ritlecitinib in cicatricial alopecia have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cicatricial Alopecia

Drugs mentioned

• Ritlecitinib (ritlecitinib)

Snippet

Sponsor: Emma Guttman | Conditions: Cicatricial Alopecia | Phase 2 | Status: COMPLETED | Results posted: 2026-07-15